230 related articles for article (PubMed ID: 16393674)
21. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
[TBL] [Abstract][Full Text] [Related]
22. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
23. Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.
Singh S; Sadanandam A; Varney ML; Nannuru KC; Singh RK
Int J Cancer; 2010 Jan; 126(2):328-36. PubMed ID: 19585580
[TBL] [Abstract][Full Text] [Related]
24. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the concentration of CXCL8 chemokine and its CXCR1 and CXCR2 receptors in peritoneal fluid of women with endometriosis.
Smycz-Kubańska M; Mamrocha A; Wendlocha D; Królewska-Daszczyńska P; Strzelec A; Stępień S; Mielczarek-Palacz A
Pol Merkur Lekarski; 2022 Aug; 50(298):232-236. PubMed ID: 36086981
[TBL] [Abstract][Full Text] [Related]
26. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
Navarro J
Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
[TBL] [Abstract][Full Text] [Related]
27. CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.
Singh S; Nannuru KC; Sadanandam A; Varney ML; Singh RK
Br J Cancer; 2009 May; 100(10):1638-46. PubMed ID: 19401689
[TBL] [Abstract][Full Text] [Related]
28. Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
Sharma B; Singh S; Varney ML; Singh RK
Expert Opin Ther Targets; 2010 Apr; 14(4):435-42. PubMed ID: 20230195
[TBL] [Abstract][Full Text] [Related]
29. Expression of interleukin-8 receptors in patients with adenomyosis.
Ulukus M; Ulukus EC; Seval Y; Cinar O; Zheng W; Arici A
Fertil Steril; 2006 Mar; 85(3):714-20. PubMed ID: 16500343
[TBL] [Abstract][Full Text] [Related]
30. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
[TBL] [Abstract][Full Text] [Related]
31. CXCL8 and its cognate receptors in melanoma progression and metastasis.
Singh S; Singh AP; Sharma B; Owen LB; Singh RK
Future Oncol; 2010 Jan; 6(1):111-6. PubMed ID: 20021212
[TBL] [Abstract][Full Text] [Related]
32. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Depasquale I; Thompson WD
Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
[TBL] [Abstract][Full Text] [Related]
33. Genome conservation between the bovine and human interleukin-8 receptor complex: improper annotation of bovine interleukin-8 receptor b identified.
Pighetti GM; Rambeaud M
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):335-40. PubMed ID: 16982101
[TBL] [Abstract][Full Text] [Related]
34. The CXCL8-CXCR1/2 pathways in cancer.
Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
[TBL] [Abstract][Full Text] [Related]
35. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.
Qiu Y; Zhu J; Bandi V; Atmar RL; Hattotuwa K; Guntupalli KK; Jeffery PK
Am J Respir Crit Care Med; 2003 Oct; 168(8):968-75. PubMed ID: 12857718
[TBL] [Abstract][Full Text] [Related]
36. CXCL8 enhances the angiogenic activity of umbilical cord blood-derived outgrowth endothelial cells in vitro.
Kimura T; Kohno H; Matsuoka Y; Murakami M; Nakatsuka R; Hase M; Yasuda K; Uemura Y; Sasaki Y; Fukuhara S; Sonoda Y
Cell Biol Int; 2011 Mar; 35(3):201-8. PubMed ID: 20958269
[TBL] [Abstract][Full Text] [Related]
37. [Effects of fluid shear stress on the expression of IL-8 receptor mRNA in EA. Hy926 cells].
Yu C; Liu X; Zhang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):303-7. PubMed ID: 17591247
[TBL] [Abstract][Full Text] [Related]
38. Cloning and pharmacological characterization of CXCR1 and CXCR2 from Macaca fascicularis.
Hipkin RW; Deno G; Fine J; Sun Y; Wilburn B; Fan X; Gonsiorek W; Wiekowski MT
J Pharmacol Exp Ther; 2004 Jul; 310(1):291-300. PubMed ID: 15028780
[TBL] [Abstract][Full Text] [Related]
39. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus.
Hsieh SC; Wu TH; Tsai CY; Li KJ; Lu MC; Wu CH; Yu CL
Rheumatology (Oxford); 2008 Feb; 47(2):150-7. PubMed ID: 18208820
[TBL] [Abstract][Full Text] [Related]
40. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
